| | Morphology | Gender | AAPC 1990-2019 (95% CI) | | ASIR | ASMR | ASRs of DALY |
| | All neoplasms | Male | 0.88 (0.81,0.96) | -0.46 (-0.58,-0.34) | -0.97 (-1.07,-0.87) | | Female | 0.51 (0.40,0.61) | -1.24 (-1.40,-1.08) | -1.66 (-1.80,-1.51) | | Both | 0.71 (0.62,0.79) | -0.80 (-0.94,-0.66) | -1.26 (-1.38,-1.14) |
| | Tracheal, bronchus, and lung cancer | Male | 1.49 (1.31,1.66) | -0.43 (-0.64,-0.21) | 0.60 (0.43,0.77) | | Female | 1.08 (0.90,1.26) | 0.67 (0.47,0.88) | 0.11 (-0.07,0.30) | | Both | 1.33 (1.16,1.50) | 0.94 (0.74,1.14) | 0.42 (0.25,0.59) |
| | Stomach cancer | Male | 0.14 (-0.21,0.50) | -1.17 (-1.58,-0.77) | -1.47 (-1.89,-1.05) | | Female | -1.60 (-1.95,-1.25) | -2.59 (-3.00,-2.17) | -3.02 (-3.41,-2.63) | | Both | -0.42 (-0.77,-0.06) | -1.68 (-2.09,-1.27) | -1.98 (-2.4,-1.57) |
| | Colorectal cancer | Male | 4.46 (4.11,4.82) | 2.21 (1.92,2.50) | 2.12 (1.81,2.43) | | Female | 2.50 (2.26,2.74) | 0.32 (0.11,0.52) | -0.03 (-0.19,0.13) | | Both | 3.66 (3.36,3.97) | 1.39 (1.13,1.64) | 1.24 (1.00,1.49) |
| | Breast cancer | Male | 8.74 (7.59,9.89) | 6.21 (5.21,7.22) | 6.59 (5.51,7.67) | | Female | 2.70 (2.60,2.79) | -0.14 (-0.21,-0.06) | -0.35 (-0.43,-0.26) | | Both | 2.84 (2.74,2.95) | 0.06 (0,0.13) | -0.13 (-0.19,-0.06) |
| | Prostate cancer | Male | 2.54 (2.44,2.64) | -0.22 (-0.27,-0.17) | -0.24 (-0.28,-0.20) | | Non-melanoma skin cancer | Male | 3.95 (3.46,4.45) | 1.27 (0.99,1.55) | 0.99 (0.73,1.25) | | Female | 3.77 (3.30,4.25) | 1.67 (1.32,2.03) | 1.16 (0.86,1.46) | | Both | 3.87 (3.39,4.35) | 1.48 (1.17,1.79) | 1.09 (0.82,1.37) |
| | Esophageal cancer | Male | -0.96 (-1.37,-0.55) | -1.21 (-1.64,-0.78) | -1.56 (-2.03,-1.10) | | Female | -2.85 (-3.45,-2.26) | -3.53 (-4.14,-2.91) | -4.11 (-4.77,-3.43) | | Both | -1.58 (-2.05,-1.11) | -1.96 (-2.44,-1.47) | -2.27 (-2.78,-1.75) |
| | Cervical cancer | Female | 1.61 (1.35,1.88) | 0.09 (-0.18,0.36) | 0.16 (-0.09,0.41) | | Leukemia | Male | -0.61 (-0.74,-0.48) | -1.60 (-1.66,-1.53) | -2.33 (-2.43,-2.24) | | Female | -1.56 (-1.84,-1.27) | -2.62 (-2.82, -2.41) | -3.37 (-3.67,-3.08) | | Both | -1.06 (-1.25,-0.86) | -2.05 (-2.17,-1.93) | -2.79 (-2.97,-2.61) |
| | Liver cancer | Male | -4.40 (-5.27,-3.53) | -4.81 (-5.66,-3.94) | -5.05 (-5.94,-4.15) | | Female | -5.16(-5.86,-4.45) | -5.42 (-6.12,-4.71) | -5.87 (-6.62,-5.1) | | Both | -4.68(-5.50,-3.84) | -5.06 (-5.88,-4.24) | -5.31 (-6.17,-4.44) |
| | Uterine cancer | Female | 1.26 (0.58,1.94) | -2.27 (-2.88,-1.66) | -2.21 (-2.81,-1.60) | | Pancreatic cancer | Male | 2.64 (2.43,2.85) | 2.55 (2.34,2.75) | 2.39 (2.17,2.62) | | Female | 1.88 (1.70,2.07) | 1.85 (1.66,2.04) | 1.45 (1.29,1.61) | | Both | 2.32 (2.12,2.51) | 2.25 (2.05,2.45) | 2.02(1.83,2.21) |
| | Brain and central nervous system cancer | Male | 0.50 (0.45,0.55) | -0.30 (-0.39,-0.21) | -0.94 (-1.04,-0.84) | | Female | 1.07 (0.97,1.18) | -0.70 (-0.83,-0.57) | -1.37 (-1.58,-1.17) | | Both | 0.76 (0.68,0.83) | -0.49 (-0.59,-0.38) | -1.13 (-1.28,-0.99) |
| | Nasopharynx cancer | Male | 2.68 (2.28,3.08) | -2.14 (-2.25,-2.03) | -2.10 (-2.22,-1.98) | | Female | 0.68 (0.44,0.91) | -3.96 (-4.15,-3.77) | -4.12 (-4.37,-3.87) | | Both | 2.07 (1.72,2.41) | -2.69 (-2.82,-2.57) | -2.71 (-2.87,-2.56) |
| | Bladder cancer | Male | 2.14 (2.02,2.26) | -0.07 (-0.12,-0.01) | -0.07 (-0.12,-0.02) | | Female | -0.10 (-0.19,-0.01) | -1.89 (-1.97,-1.81) | -2.20 (-2.29,-2.12) | | Both | 1.74 (1.63,1.85) | -0.53 (-0.58,-0.49) | -0.58 (-0.64,-0.53) |
| | Non-Hodgkin lymphoma | Male | 4.58 (4.17,5.00) | 2.06 (1.75,2.36) | 1.66 (1.37,1.95) | | Female | 2.38 (2.15,2.60) | -0.13 (-0.32,0.05) | -0.75(-1.03,-0.46) | | Both | 3.72 (3.40,4.04) | 1.20 (0.98,1.43) | 0.74 (0.51,0.97) |
| | Ovarian cancer | Female | 1.88 (1.79,1.98) | 1.52 (1.42,1.61) | 1.15 (1.04,1.25) |
| | Kidney cancer | Male | 5.46 (4.88,6.05) | 3.82 (3.30,4.34) | 3.33 (2.82,3.85) | | Female | 2.80 (2.38,3.23) | 1.17 (0.80,1.53) | 0.55 (0.19,0.90) | | Both | 4.46 (3.95,4.98) | 2.79 (2.33,3.26) | 2.28 (1.84,2.73) |
| | Testicular cancer | Male | 5.38 (5.22,5.54) | -0.43 (-0.64,-0.21) | -0.25 (-0.47,-0.04) |
| | Lip and oral cavity cancer | Male | 3.57 (3.13,4.00) | 2.56 (2.17,2.96) | 2.41 (2.02,2.81) | | Female | -0.10 (-0.19,-0.02) | -1.17 (-1.23,-1.11) | -1.57 (-1.66,-1.48) | | Both | 2.33 (2.02,2.64) | 1.44 (1.14,1.73) | 1.24 (0.96,1.52) |
| | Larynx cancer | Male | 1.59 (1.37,1.81) | -0.74 (-0.86,-0.63) | -0.94 (-1.04,-0.84) | | Female | -0.02 (-0.32,0.28) | -1.83 (-2.05,-1.62) | -2.23 (-2.41,-2.06) | | Both | 1.32 (1.11,1.54) | -0.96 (-1.07,-0.86) | -1.21 (-1.30,-1.12) |
| | Thyroid cancer | Male | 4.99 (4.59,5.39) | 2.20 (1.86,2.54) | 1.84 (1.56,2.13) | | Female | 1.57 (1.45,1.68) | -1.79 (-1.86,-1.71) | -2.00 (-2.11,-1.90) | | Both | 2.73 (2.58,2.88) | 0.06 (-0.09,0.21) | -0.20 (-0.31,-0.10) |
| | Gallbladder and biliary tract cancer | Male | 2.10 (1.66,2.55) | 1.68 (1.25,2.11) | 1.55 (1.1,1.99) | | Female | 1.07 (0.60,1.55) | 0.58 (0.12,1.04) | 0.30 (-0.14,0.75) | | Both | 1.56 (1.1,2.02) | 1.10 (0.65,1.54) | 0.93 (0.49,1.37) |
| | Multiple myeloma | Male | 1.85 (1.76,1.95) | 0.93 (0.85,1.00) | 0.87 (0.80,0.94) | | Female | 0.10 (0.03,0.18) | -0.64 (-0.71,-0.56) | -0.64 (-0.73,-0.54) | | Both | 1.04 (0.96,1.12) | 0.17 (0.10,0.23) | 0.17 (0.10,0.25) |
| | Malignant skin melanoma | Male | 3.23 (2.91,3.55) | -0.58 (-0.67,-0.48) | -0.55 (-0.67,-0.43) | | Female | 3.49 (3.18,3.80) | -0.32 (-0.45,-0.18) | -0.55 (-0.70,-0.41) | | Both | 3.35 (3.03,3.67) | -0.45 (-0.56,-0.33) | -0.56 (-0.69,-0.43) |
| | Hodgkin lymphoma | Male | -0.11 (-0.54,0.32) | -4.39 (-4.63,-4.14) | -4.69 (-4.97,-4.40) | | Female | -1.13 (-1.57,-0.69) | -5.34 (-5.67,-5.01) | -5.67 (-6.09,-5.26) | | Both | -0.54 (-0.96,-0.13) | -4.77 (-5.04,-4.50) | -5.07 (-5.4,-4.75) |
| | Other pharynx cancer | Male | 0.92 (0.59,1.24) | -0.80 (-1.04,-0.56) | -0.91 (-1.12,-0.69) | | Female | 0.87 (0.61,1.13) | -2.01 (-2.12,-1.90) | -2.38 (-2.47,-2.30) | | Both | 0.96 (0.67,1.24) | -1.01 (-1.19,-0.83) | -1.21 (-1.39,-1.04) |
| | Mesothelioma | Male | 2.26 (1.78,2.75) | 2.32 (1.83,2.82) | 2.42(1.92,2.92) | | Female | -0.66 (-0.83,-0.48) | -0.59 (-0.78,-0.41) | -0.89(-1.03,-0.75) | | Both | 0.91 (0.57,1.26) | 0.93 (0.59,1.28) | 0.95(0.61,1.30) |
|
|
